Zomedica (NYSEAMERICAN:ZOM) Trading Down 2.8% – Here’s What Happened

Zomedica Corp. (NYSEAMERICAN:ZOM)’s stock price dropped 2.8% on Wednesday . The stock traded as low as $0.12 and last traded at $0.12. Approximately 5,779,875 shares changed hands during trading, an increase of 20% from the average daily volume of 4,808,725 shares. The stock had previously closed at $0.12.

Wall Street Analysts Forecast Growth

Separately, Noble Financial raised shares of Zomedica to a “strong-buy” rating in a report on Monday, November 11th.

Zomedica Stock Up 4.4 %

The stock has a market cap of $122.79 million, a P/E ratio of -2.09 and a beta of 1.04.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Zomedica stock. Jane Street Group LLC acquired a new position in shares of Zomedica Corp. (NYSEAMERICAN:ZOM) in the 3rd quarter, according to its most recent filing with the SEC. The fund acquired 179,074 shares of the company’s stock, valued at approximately $25,000. 8.95% of the stock is currently owned by hedge funds and other institutional investors.

About Zomedica

Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company offers diagnostic products comprising TRUFORMA Bulk Acoustic Wave point of care diagnostic platform; TRUVIEW, a digital cystoscopy platform that offers automated slide preparation within the instrument; and VetGuardian, a zero-touch vital signs remote monitoring system.